Palomar Medical Tech (PMTI) Posts Wider than Expected Q3 Loss of 25c/Sh.

Palomar Medical Tech (NASDAQ: PMTI) reported Q3 EPS of ($0.25), $0.19 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.48 million versus the consensus estimate of $19.4 million.

For earnings history and earnings-related data on Palomar Medical Tech (PMTI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance